SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
LIGAND PHARMACEUTICALS INC
(NQNM:LGND Last Sale: 95.78 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (LGND : $95.78)
$1,537,241 million Market Cap at Market Close, July 1, 2022
Employs 490.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

10275 Science Center Drive Research Report World View
San Diego, CA 92121 Fact Sheet Earnings Snapshot - Last 10/27/18
Phone: 858-550-7500 Financial Statements
Peer Comparison
Annual Reports

David E. Robinson, Chmn./Pres./CEO, Paul V. Maier, CFO
Develops drugs that regulate hormone activated intracellular receptors (IRs). IRs help regulate the genetic processes affecting many diseases, including cancer, cardiovascular, inflammatory & skin diseases. Transfer to Pink Sheets (LGND) September 2, 2005.
Historical Charts    Technical Analysis
No Historical Data available for LGND

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common LGND $95.78 $95.78 0 .0 $91.82 $95.8 334,826 $91.82 $95.8 16,049,703
Rights LGNDZ $.0185 $ 0 $.0185 $.0185 150 $.009 $.03 0
Rights LGNXZ $.066 $ 0 $.066 $.066 150 $.005 $.125 0
Rights LGNYZ $.036 $ 0 $.036 $.036 150 $.0001 $.05 0
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
17-DEC-10 LGND Split 1 for 6
14-JUN-06 LGNDE Symbol Changed to LGND
24-MAR-05 LGND Symbol Changed to LGNDE

A2442
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex